Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and Insemination

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to test if recombinant follicle stimulating hormone (rFSH) given in individual doses, according to a nomogram we have constructed based on our results from a previous study, results in more patients maturing 2-3 follicles compared to standard dose.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nina la Cour Freiesleben
• Treatments: Follicle Stimulating Hormone

Criteria

Inclusion Criteria:

• Age between 25-39 years

• First stimulation with rFSH only

• Indication for intrauterine insemination with standard rFSH starting dose

• Regular menstrual bleeding with a cycle between 21-35 days

• Two ovaries

• Bilateral tuba patency

• Semen analysis must be sufficient for insemination according to the diagnostic analysis.

Exclusion Criteria:

• More than three former stimulated intrauterine insemination cycles